Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
28.73%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 5.45Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | 28.73% | $ 44.22M | $ 153.95M |
| 3/31/2025 | 19.62% | $ 31.17M | $ 158.82M |
| 12/31/2024 | 23.38% | $ 38.86M | $ 166.21M |
| 9/30/2024 | 21.39% | $ 33.68M | $ 157.46M |
| 6/30/2024 | 22.6% | $ 33.25M | $ 147.1M |
| 3/31/2024 | 21.93% | $ 35.47M | $ 161.72M |
| 12/31/2023 | 16.29% | $ 26.87M | $ 164.93M |
| 9/30/2023 | 15.99% | $ 24.14M | $ 150.96M |
| 6/30/2023 | 21.5% | $ 30.81M | $ 143.34M |
| 3/31/2023 | 9.83% | $ 13.71M | $ 139.48M |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) CROIC stands at 6.35%.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average CROIC has been 9.83%.
- The median CROIC for PUMA BIOTECHNOLOGY INC during this period was 17.19%
- PUMA BIOTECHNOLOGY INC reached its highest CROIC over the past 5 years at 28.73%.
- The lowest CROIC recorded by PUMA BIOTECHNOLOGY INC in the same timeframe -26.4%
PUMA BIOTECHNOLOGY INC's CROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CROIC Benchmarks
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for PUMA BIOTECHNOLOGY INC is calculated as follows: FCF [ $ 7.64M ] / Inv. Capital [ $ 120.31M ]
(=) CROIC [ 6.35% ] PBYI - Cash Return on Invested Capital, Last 5 years
-26.4%
Minimum
Jun 30, 2022
28.73%
Maximum
Jun 30, 2025
9.83%
Average
17.19%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.78% with a standard deviation of 15.05%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.3% |
| average | 2.78% |
| median | 4.97% |
| std | 15.05% |